Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500104357Phase 4Not yet recruiting
Phase 4, randomised trial of ropivacaine and sufentanil in labor pain (2 arms), sponsored by Xinyang Central Hospital. Primary endpoints: Time required to achieve effective analgesia after initial administration, Neonatal Apgar score and 1 more. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500104357.